Reports
Sale
Global Sepsis Diagnostics Market Size, Trends, Analysis, Report: By Product Type: Instruments, Blood Culture Media, Assay Kits and Reagents, Software; By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Others; By Pathogen, By Type; By Methods; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Sepsis Diagnostics Market Outlook
The global sepsis diagnostics market size was valued at USD 725.6 million in 2023, driven by the rising merger and acquisitions amongst companies to offer early diagnosis of the condition. The market is expected to grow at a CAGR of 9.1% during the forecast period of 2024-2032, with the values likely to rise from USD 791.6 million in 2024 to USD 1587.4 million by 2032.
Sepsis Diagnostics: Introduction
Sepsis is a condition characterized by the body’s abnormal response to an infection. Common symptoms may include sweating, shivering, change in mental status, and shallow breathing, among others. The condition can be diagnosed via blood tests, which help in detecting evidence of infection, abnormal liver or kidney function, electrolyte imbalances or blood clotting issues. The imaging tests may include x-ray, ultrasound, CT scans, and MRIs.
Global Sepsis Diagnostics Market Analysis
Sepsis is one of the leading causes of deaths in the world. As per studies, early diagnosis can significantly help lower the fatalities associated with the condition. Therefore, there has been rising demand for sepsis diagnostics.
The sepsis diagnostics market growth is driven by the rising merger and acquisitions amongst companies to offer early diagnosis of the condition. In September 2023, Acutelines, a data-biobank and Inflammatix, a molecular diagnostics company announced their strategic partnership to develop a smart tool that helps in the recognition of sepsis while supporting clinical decisions in the early stages of the disease. This can mark as a crucial step since early recognition can be quite difficult in this condition.
With deeper understanding of human physiology and improved biotechnology techniques, the market for sepsis diagnostics has been experiencing major advancements. For instance, In November 2023, Abionic, along with their biomedical technology partner Lascco, entered a licensing agreement with Fapon, to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis.
SeptiCyte® RAPID by Immunexpress is another molecular test for sepsis diagnosis that employs the RT-PCR test to quantify the level of host response genes. It is intended for in-vitro diagnostic use and runs on the Biocartis Idylla™ Platform. Emerging technologies like these will certainly benefit the sepsis diagnostics market value in the forecast period.
Global Sepsis Diagnostics Market Segmentation
Market Breakup by Product Type
- Instruments
- Blood Culture Media
- Assay Kits and Reagents
- Software
Market Breakup by Technology
- Microbiology
- Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- DNA Microarrays
- Syndromic Panel Testing
- Others
- Immunoassays
- Flow Cytometry
- Others
Market Breakup by Pathogen
- Bacterial Sepsis
- Gram-positive Bacteria
- Gram-negative Bacteria
- Fungal Sepsis
- Viral Sepsis
- Others
Market Breakup by Type
- Laboratory Testing
- POC Testing
Market Breakup by Methods
- Automated Diagnostics
- Conventional Diagnostics
Market Breakup by End User
- Hospitals and Clinics
- Pathology and Reference Laboratories
- Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Sepsis Diagnostics Market Overview
The United States holds a substantial part of the sepsis diagnostics market share owing to a robust healthcare infrastructure. Increasing effort of the government and private institutions to offer awareness about the condition also plays a vital role for market growth. In July 2023, the Society of Critical Care Medicine (SCCM) received a grant from the Council of Medical Specialty Societies to enhance diagnostic excellence. The diagnostic program by SCCM focuses on providing knowledge and technology for precise diagnosis with the help of podcasts, toolkits, and webcasts.
The Asia Pacific region is projected to witness further growth with the increasing sepsis diagnostics market demand in the region. With increasing mergers and collaborations, the government has also been working on improving the medical infrastructure with a vision to integrate all digital and artificial intelligence-based tools into the system. A large population base spanning from the old as well as young generations is another essential factor for increased market demand.
Global Sepsis Diagnostics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- BioMérieux SA
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Luminex Corp.
- Bruker Corp.
- Cepheid
- Bruker Corporation
- Immunexpress, Inc.
- Nanosphere, Inc.
- Seegene Inc.
- Response Biomedical Corp.
- Quidel Corporation
- Koninklijke Philips N.V.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Pathogen |
|
| Breakup by Type |
|
| Breakup by Methods |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Sepsis Diagnostics Market Overview
3.1 Global Sepsis Diagnostics Market Historical Value (2017-2023)
3.2 Global Sepsis Diagnostics Market Forecast Value (2024-2032)
4 Global Sepsis Diagnostics Market Landscape
4.1 Global Sepsis Diagnostics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Sepsis Diagnostics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Pathogen
5 Global Sepsis Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Sepsis Diagnostics Market Segmentation
6.1 Global Sepsis Diagnostics Market by Product Type
6.1.1 Market Overview
6.1.2 Instruments
6.1.3 Blood Culture Media
6.1.4 Assay Kits and Reagents
6.1.5 Software
6.2 Global Sepsis Diagnostics Market by Technology
6.2.1 Market Overview
6.2.2 Microbiology
6.2.3 Molecular Diagnostics
6.2.3.1 Polymerase Chain Reaction (PCR)
6.2.3.2 DNA Microarrays
6.2.3.3 Syndromic Panel Testing
6.2.3.4 Others
6.2.4 Immunoassays
6.2.5 Flow Cytometry
6.2.6 Others
6.3 Global Sepsis Diagnostics Market by Pathogen
6.3.1 Market Overview
6.3.2 Bacterial Sepsis
6.3.2.1 Gram-positive Bacteria
6.3.2.2 Gram-negative Bacteria
6.3.3 Fungal Sepsis
6.3.4 Viral Sepsis
6.3.5 Others
6.4 Global Sepsis Diagnostics Market by Type
6.4.1 Market Overview
6.4.2 Laboratory Testing
6.4.3 POC Testing
6.5 Global Sepsis Diagnostics Market by Methods
6.5.1 Market Overview
6.5.2 Automated Diagnostics
6.5.3 Conventional Diagnostics
6.6 Global Sepsis Diagnostics Market by End User
6.6.1 Market Overview
6.6.2 Hospitals and Clinics
6.6.3 Pathology and Reference Laboratories
6.6.4 Research Institutes
6.6.5 Others
6.7 Global Sepsis Diagnostics Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Sepsis Diagnostics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Sepsis Diagnostics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Sepsis Diagnostics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Sepsis Diagnostics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Sepsis Diagnostics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 BioMérieux SA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Thermo Fisher Scientific, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 F. Hoffmann-La Roche AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Luminex Corp.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Bruker Corp.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Cepheid
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Bruker Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Immunexpress, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Nanosphere, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Seegene Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Response Biomedical Corp.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Quidel Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Koninklijke Philips N.V.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Sepsis Diagnostics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 725.6 million in 2023, driven by the rising incidence of sepsis across the globe.
The market is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032, likely to reach a market value of USD 1587.4 million by 2032.
The market demand is driven by the emphasis on reducing the number of mortalities associated with sepsis across the globe.
The current market trend revolves around rising mergers between companies. In September 2023, Acutelines and Inflammatix announced their partnership to develop a smart tool that helps in the recognition of sepsis while supporting clinical decisions in the early stages of sepsis.
Based on product types, the market is divided into instruments, blood culture media, assay kits, reagents and software.
Technologies in the market include microbiology, molecular diagnostics, immunoassays, and flow cytometry, among others. Molecular diagnostics are further divided into polymerase chain reaction (PCR), DNA microarrays, and syndromic panel testing, among others.
Pathogens can be divided into bacterial sepsis, fungal sepsis, and viral sepsis, among others. Bacterial sepsis can be further categorised into gram-positive bacteria and gram-negative bacteria.
The types can be categorised into laboratory testing and POC testing.
Major end users include hospitals, clinics, pathology, reference laboratories, and research institutes, among others.
It includes both automated and conventional diagnostics.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation, Luminex Corp., Bruker Corp., Bruker Corporation, Immunexpress, Inc., Nanosphere, Inc., Seegene Inc., Response Biomedical Corp., Quidel Corporation, and Koninklijke Philips N.V., and Cepheid.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER